New drug SUL-238 put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested the safety of a new experimental drug, SUL-238, in 83 healthy adults aged 40 and older. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was not to treat …
Phase: PHASE1 • Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC